Whether semaglutide works best as a short-term intervention or long-term maintenance depends on your individual metabolic response, baseline metabolic health, and genetic factors affecting GLP-1 signaling
In terms of safety, clinical trials have generally found semaglutide to be well-tolerated
At 1500mg IV, plasma glutathione levels rise significantly within minutes, delivering immediate systemic antioxidant support
Other licensed weight loss medications Retatrutide, although still undergoing clinical trials, will likely have once weekly injection dosing as similar to Mounjaro and Wegovy
The growing influence of GLP-1 therapies may be a catalyst for some of those shifts
Like other synthetic peptides, it is produced through controlled peptide synthesis techniques to ensure sequence accuracy and purity